Statistics
Publications
11
Citations
1.3K
H-Index
11
Active since
2006
Diederik van Bodegom is an author at Dana-Farber Cancer Institute specializing in molecular oncology, oncology, and molecular biology.
Publications per year
2006–2016
11
11
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
Oreofe O. Odejide, Oliver Weigert, Andrew A. Lane et al. · Blood · 2013 · 429 citations · Full text
Medicine, Hematology, Oncology +11
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 162 citations · Full text
Medicine, Oncology, Pharmacology +14
p53 regulates a non-apoptotic death induced by ROS
Joan Montero, Chaitali Dutta, Diederik van Bodegom et al. · Cell Death and Differentiation · 2013 · 138 citations · Full text
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia
Shuo-Chieh Wu, Loretta S. Li, Nadja Kopp et al. · Cancer Cell · 2015 · 123 citations · Full text
Medicine, Oncology, Pharmacology +8
1–5 of 11